Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Complementary Medicine and Therapies
Published in: BMC Complementary Medicine and Therapies 1/2021

Open Access 01-12-2021 | Research article

The role of pharmacists in complementary and alternative medicine in Lebanon: users’ perspectives

Authors: Mohamad Ali Hijazi, Hibeh Shatila, Zeina Omeich, Abdalla El-Lakany, Maha Aboul Ela, Farah Naja

Published in: BMC Complementary Medicine and Therapies | Issue 1/2021

Login to get access

Abstract

Background

Customers’ expectations and satisfaction are critical to ensure a more effective role of the community pharmacists in promoting the safe use of Complementary and Alternative Medicine (CAM). The aim of this study is to examine the perceptions and practices of customers buying their CAM products from pharmacies and explore their satisfaction with CAM-related services offered by the community pharmacists in Lebanon.

Methods

A national cross-sectional study was conducted among users of CAM (age > =18 years) who obtained their CAM from community pharmacies in Lebanon (n = 832). Within the proximity of the pharmacy, subjects were invited to complete a multi-component questionnaire. The latter consisted of four sections related to CAM: general beliefs, perception of pharmacists’ role, practices, satisfaction with services offered by the pharmacists. In addition, the questionnaire included questions about sociodemographic characteristics of participants.

Results

The majority of participants agreed to an active role of the pharmacists’ in guiding CAM use, however over half of the participants (61.3%) did not agree that the pharmacist is more knowledgeable in this field than other healthcare providers. As for practices, one in two surveyed customers (47%) did not always give feedback to their pharmacists about the outcomes after using CAM, 20% did not often ask the pharmacists about the safe and effective mode of use of the products and 28.1% did not discuss their medical history. For services offered by the pharmacist, the majority of participants reported receiving good education about the CAM product (87.1%), its side effects (87.1%) and mode of use (93.4%), while significant proportions of participants reported that pharmacists were not asking questions about their medical history before dispensing CAM products (22%) nor were they providing information on CAM-drug interactions (30%).

Conclusions

The results of this study highlighted important gaps between the perceptions of customers and the services they received from the pharmacists about CAM use. These findings could be used by concerned stakeholders, including public health authorities and educational bodies, to develop evidence-based interventions aimed at promoting the role of pharmacists in ensuring a safe and effective CAM use Lebanon.
Appendix
Available only for authorised users
Literature
1.
2.
Wagner C. Complementary and alternative medicine: the United States healthcare system: overview, driving forces, and outlook …; 2020.
3.
Asmelashe Gelayee D, Binega Mekonnen G, Asrade Atnafe S, Birarra MK, Asrie AB. Herbal medicines: personal use, knowledge, attitude, dispensing practice, and the barriers among community pharmacists in Gondar, Northwest Ethiopia. Evid Based Complement Alternat Med. 2017;2017:6480142.
4.
AlBraik FA, Rutter PM, Brown D. A cross-sectional survey of herbal remedy taking by united Arab emirate (UAE) citizens in Abu Dhabi. Pharmacoepidemiol Drug Saf. 2008;17(7):725–32.PubMedCrossRef
5.
Al-Faris EA, Al-Rowais N, Mohamed AG, Al-Rukban MO, Al-Kurdi A, Balla Al-Noor MA, et al. Prevalence and pattern of alternative medicine use: the results of a household survey. Ann Saudi Med. 2008;28(1):4–10.PubMedPubMedCentral
6.
Naja F, Alameddine M, Itani L, Shoaib H, Hariri D, Talhouk S. The use of complementary and alternative medicine among lebanese adults: results from a national survey. Evid Based Complement Alternat Med. 2015;2015:682397.
7.
Iyer P, McFarland R, La Caze A. Expectations and responsibilities regarding the sale of complementary medicines in pharmacies: perspectives of consumers and pharmacy support staff. Int J Pharm Pract. 2017;25(4):292–300.PubMedCrossRef
8.
Ahmed N, el Hassan A. Traditional remedies and lead intoxication. Trop Geogr Med. 1987;39(1):100–3.PubMed
9.
Khader Y, Sawair FA, Ayoub A, Ayoub N, Burgan SZ, Amarin Z. Knowledge and attitudes of lay public, pharmacists, and physicians toward the use of herbal products in North Jordan. J Altern Complement Med. 2008;14(10):1186–7.PubMedCrossRef
10.
Awad A, Al-Ajmi S, Waheedi M. Knowledge, perceptions and attitudes toward complementary and alternative therapies among Kuwaiti medical and pharmacy students. Med Princ Pract. 2012;21(4):350–4.PubMedCrossRef
11.
Abahussain NA, Abahussain EA, Al-Oumi FM. Pharmacists’ attitudes and awareness towards the use and safety of herbs in Kuwait. Pharma Pract. 2007;5(3):125–9.
12.
Duraz AY, Khan SA. Knowledge, attitudes and awareness of community pharmacists towards the use of herbal medicines in Muscat region. Oman Med J. 2011;26(6):451.PubMedPubMedCentralCrossRef
13.
Alkharfy K. Community pharmacists’ knowledge, attitudes and practices towards herbal remedies in Riyadh, Saudi Arabia/Connaissances, attitudes et pratiques des pharmaciens communautaires Vis-a-Vis des medicaments a base de plantes a Riyad (Arabie saoudite). East Mediterr Health J. 2010;16(9):988.PubMedCrossRef
14.
Ghazeeri GS, Awwad JT, Alameddine M, Younes ZM, Naja F. Prevalence and determinants of complementary and alternative medicine use among infertile patients in Lebanon: a cross sectional study. BMC Complement Altern Med. 2012;12(1):129.PubMedPubMedCentralCrossRef
15.
Naja F, Anouti B, Shatila H, Akel R, Haibe Y, Tfayli A. Prevalence and correlates of complementary and alternative medicine use among patients with lung Cancer: a cross-sectional study in Beirut, Lebanon. Evid Based Complement Alternat Med. 2017;2017:8434697.
16.
Abou-Rizk J, Alameddine M, Naja F. Prevalence and characteristics of CAM use among people living with HIV and AIDS in Lebanon: implications for patient care. Evid Based Complement Alternat Med. 2016;2016:5013132.
17.
Alameddine M, Naja F, Abdel-Salam S, Maalouf S, Matta C. Stakeholders’ perspectives on the regulation and integration of complementary and alternative medicine products in Lebanon: a qualitative study. BMC Complement Altern Med. 2011;11(1):71.PubMedPubMedCentralCrossRef
18.
Naja F, Alameddine M, Abboud M, Bustami D, Al HR. Complementary and alternative medicine use among pediatric patients with leukemia: the case of Lebanon. Integr Cancer Ther. 2011;10(1):38–46.PubMedCrossRef
19.
Naja F, Fadel RA, Alameddine M, Aridi Y, Zarif A, Hariri D, et al. Complementary and alternative medicine use and its association with quality of life among Lebanese breast cancer patients: a cross-sectional study. BMC Complement Altern Med. 2015;15(1):444.PubMedPubMedCentralCrossRef
20.
Naja F, Mousa D, Alameddine M, Shoaib H, Itani L, Mourad Y. Prevalence and correlates of complementary and alternative medicine use among diabetic patients in Beirut, Lebanon: a cross-sectional study. BMC Complement Altern Med. 2014;14(1):185.PubMedPubMedCentralCrossRef
21.
Astin JA. Why patients use alternative medicine: results of a national study. JAMA. 1998;279(19):1548–53.PubMedCrossRef
22.
Azaizeh H, Saad B, Khalil K, Said O. The state of the art of traditional Arab herbal medicine in the eastern region of the Mediterranean: a review. Evid Based Complement Alternat Med. 2006;3(2):229–35.PubMedPubMedCentralCrossRef
23.
Gray L, Chamberlain R, Morris C. “Basically you wait for an ‘in”’: community pharmacist views on their role in weight management in New Zealand. J Prim Health Care. 2016;8(4):365–71.PubMedCrossRef
24.
Hijazi MA, Shatila H, El-Lakany A, Al Rifai H, Aboul-Ela M, Naja F. Role of community pharmacists in weight management: results of a national study in Lebanon. BMC Health Serv Res. 2020;20(1):386.PubMedPubMedCentralCrossRef
25.
Naidu S, Wilkinson JM, Simpson MD. Attitudes of Australian pharmacists toward complementary and alternative medicines. Ann Pharmacother. 2005;39(9):1456–61.PubMedCrossRef
26.
Shraim NY, Shawahna R, Sorady MA, Aiesh BM, Alashqar GS, Jitan RI, et al. Community pharmacists’ knowledge, practices and beliefs about complementary and alternative medicine in Palestine: a cross-sectional study. BMC Complement Altern Med. 2017;17(1):1–12.CrossRef
27.
Ung COL, Harnett J, Hu H. Community pharmacist's responsibilities with regards to traditional medicine/complementary medicine products: a systematic literature review. Res Soc Adm Pharm. 2017;13(4):686–716.CrossRef
28.
29.
Hassali M, Shafie A, Khan T. General public expectation from the communication process with their healthcare providers. J Young Pharm. 2012;4(3):193–8.PubMedPubMedCentralCrossRef
30.
Worley MM, Schommer JC, Brown LM, Hadsall RS, Ranelli PL, Stratton TP, et al. Pharmacists’ and patients’ roles in the pharmacist-patient relationship: are pharmacists and patients reading from the same relationship script? Res Soc Adm Pharm. 2007;3(1):47–69.CrossRef
31.
32.
Kucukarslan SN, Nadkarni A. Evaluating medication-related services in a hospital setting using the disconfirmation of expectations model of satisfaction. Res Soc Adm Pharm. 2008;4(1):12–22.CrossRef
33.
Jose J, Al Shukili MN, Jimmy B. Public’s perception and satisfaction on the roles and services provided by pharmacists–cross sectional survey in Sultanate of Oman. Saudi Pharm J. 2015;23(6):635–41.PubMedPubMedCentralCrossRef
34.
McMillan SS, Kelly F, Sav A, King MA, Whitty JA, Wheeler AJ. Australian community pharmacy services: a survey of what people with chronic conditions and their carers use versus what they consider important. BMJ open. 2014;4(12):e006587.
35.
Alfadl AA, Alrasheedy AA, Alhassun MS. Evaluation of medication counseling practice at community pharmacies in Qassim region, Saudi Arabia. Saudi Pharm J. 2018;26(2):258–62.PubMedCrossRef
36.
Malewski DF, Ream A, Gaither CA. Patient satisfaction with community pharmacy: comparing urban and suburban chain-pharmacy populations. Res Soc Adm Pharm. 2015;11(1):121–8.CrossRef
37.
Yang S, Kim D, Choi HJ, Chang MJ. A comparison of patients’ and pharmacists’ satisfaction with medication counseling provided by community pharmacies: a cross-sectional survey. BMC Health Serv Res. 2016;16(1):1–8.CrossRef
38.
Al-Arifi MN. Patients’ perception, views and satisfaction with pharmacists’ role as health care provider in community pharmacy setting at Riyadh, Saudi Arabia. Saudi Pharm J. 2012;20(4):323–30.PubMedPubMedCentralCrossRef
39.
Basheti IA, Qunaibi EA, Hamadi SA, Abu-Gharbieh E, Saleh S, AbuRuz S, et al. Patient perspectives of the role of the community pharmacist in the Middle East: Jordan, United Arab Emirates and Iraq. Pharmacol Pharm. 2014;5(06):588.CrossRef
40.
Fahmy SA, Abdu S, Abuelkhair M. Pharmacists’ attitude, perceptions and knowledge towards the use of herbal products in Abu Dhabi, United Arab Emirates. Pharm Pract. 2010;8(2):109.
41.
Zhang J, Onakpoya IJ, Posadzki P, Eddouks M. The safety of herbal medicine: from prejudice to evidence. Evidence-based complementaryand alternative medicine : eCAM. 2015;316706.
42.
Bahall M, Edwards M. Perceptions of complementary and alternative medicine among cardiac patients in South Trinidad: a qualitative study. BMC Complement Altern Med. 2015;15(1):99.PubMedPubMedCentralCrossRef
43.
Zhang J, Wider B, Shang H, Li X, Ernst E. Quality of herbal medicines: challenges and solutions. Complement Ther Med. 2012;20(1–2):100–6.PubMedCrossRef
44.
Boullata JI, Nace AM. Safety issues with herbal medicine. Pharmacother. 2000;20(3):257–69.CrossRef
45.
Hijazi MA, Shatila H, El-Lakany A, Ela MA, Kharroubi S, Alameddine M, et al. Beliefs, practices and knowledge of community pharmacists regarding complementary and alternative medicine: national cross-sectional study in Lebanon. BMJ Open. 2019;9(3):e025074.PubMedPubMedCentralCrossRef
46.
Awad AI, Al-Rasheedi A, Lemay J. Public perceptions, expectations, and views of community pharmacy practice in Kuwait. Med Princ Pract. 2017;26(5):438–46.PubMedPubMedCentralCrossRef
47.
Anderson C, Blenkinsopp A, Armstrong M. Feedback from community pharmacy users on the contribution of community pharmacy to improving the public's health: a systematic review of the peer reviewed and non-peer reviewed literature 1990–2002. Health Expect. 2004;7(3):191–202.PubMedPubMedCentralCrossRef
48.
49.
Hall A, Miguel A, Weitzel K. Providing feedback to learners in outpatient and ambulatory care practice settings. Curr Pharm Teach Learn. 2015;7(3):348–56.CrossRef
50.
51.
Shelley BM, Sussman AL, Williams RL, Segal AR, Crabtree BF. ‘They don’t ask me so I don’t tell them’: patient-clinician communication about traditional, complementary, and alternative medicine. Ann Fam Med. 2009;7(2):139–47.PubMedPubMedCentralCrossRef
52.
Iskandar K, Hallit S, Raad EB, Droubi F, Layoun N, Salameh P. Community pharmacy in Lebanon: A societal perspective. Pharm Pract. 2017;15(2):893.
53.
Ibrahim IR, Al Tukmagi HF, Wayyes A. Attitudes of Iraqi society towards the role of community pharmacists. Innov Pharm. 2013;4(2).
54.
Tarn DM, Paterniti DA, Wenger NS, Williams BR, Chewning BA. Older patient, physician and pharmacist perspectives about community pharmacists’ roles. Int J Pharm Pract. 2012;20(5):285–93.PubMedPubMedCentralCrossRef
55.
Xu KT. Choice of and overall satisfaction with pharmacies among a community-dwelling elderly population. Med Care. 2002:1283–93.
56.
Kelly DV, Young S, Phillips L, Clark D. Patient attitudes regarding the role of the pharmacist and interest in expanded pharmacist services. Can Pharm J (Ott). 2014;147(4):239–47.CrossRef
57.
Alameddine M, Bou Karroum K, Hijazi MA. Upscaling the pharmacy profession in Lebanon: workforce distribution and key improvement opportunities. Hum Resour Health. 2019;17(1):47.PubMedPubMedCentralCrossRef
58.
Puspitasari HP, Aslani P, Krass I. Retos en el manejo de enfermedades crónicas no declarables por los farmacéuticos comunitarios indonesios. Pharm Pract. 2015;13(3):0.
59.
Elnaem MH, Jamshed SQ, Elkalmi R. Knowledge of the risk factors of non-communicable diseases (NCDs) among pharmacy students: findings from a Malaysian University. Int J Health Promot Educ. 2019;57(4):217–28.CrossRef
60.
ASHP therapeutic position statement on the safe use of pharmacotherapy for obesity management in adults. Developed by the ASHP Commission on Therapeutics and approved by the ASHP Board of Directors on April 23, 2001. Am J Health Syst Pharm. 2001;58(17):1645–55.
61.
Kelak JA, Cheah WL, Safii R. Patient’s decision to disclose the use of traditional and complementary medicine to medical doctor: a descriptive phenomenology study. Evid Based Complement Alternat Med. 2018;2018:4735234.
62.
Ung COL, Harnett J, Hu H. Development of a strategic model for integrating complementary medicines into professional pharmacy practice. Res Soc Adm Pharm. 2018;14(7):663–72.CrossRef
Metadata
Title
The role of pharmacists in complementary and alternative medicine in Lebanon: users’ perspectives
Authors
Mohamad Ali Hijazi
Hibeh Shatila
Zeina Omeich
Abdalla El-Lakany
Maha Aboul Ela
Farah Naja
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2021
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/s12906-021-03256-8

Other articles of this Issue 1/2021

BMC Complementary Medicine and Therapies 1/2021 Go to the issue

Research article

Bioactive fractions and compound of Ardisia crispa roots exhibit anti-arthritic properties mediated via angiogenesis inhibition in vitro

Research article

In-vitro Immunomodulatory activity of Azadirachta indica A.Juss. Ethanol: water mixture against HIV associated chronic CD4+ T-cell activation/ exhaustion

Research article

Up-regulation of long non-coding RNA CYTOR induced by icariin promotes the viability and inhibits the apoptosis of chondrocytes

Research

Protective effects of exosomes derived from lyophilized porcine liver against acetaminophen damage on HepG2 cells

Research article

Potential natural inhibitors of xanthine oxidase and HMG-CoA reductase in cholesterol regulation: in silico analysis

Research

Homogeneous polyporus polysaccharide inhibits bladder cancer by polarizing macrophages to M1 subtype in tumor microenvironment